Financial intelligence for Asia's healthcare markets
Remember me:


Category disruption

HealthInvestor Asia talks with Abel Ang, group chief executive officer of Accuron MedTech. Listen in for insights into his activities in the region and some investments he has been making in category disruptors.

Asia's aging population

HealthInvestor Asia talks with Jonathan Tan, director of the Asia Pacific Risk Centre for the Marsh & McLennan Companies in Singapore. Listen in for insights into the challenges of the aging population to Asia.

Healthcare market snapshot

HealthInvestor Asia talks with Saurabh Gupta, head of healthcare and consumer at Maybank Kim Eng in Singapore. Listen in for insights into the capital markets and healthcare.

Aged Care in China

HealthInvestor Asia talks with John Mortensen, regional director for healthcare and education, Greater China for real estate specialist JLL. Listen in for insights into aged care in China.

Don't miss a podcast. Subscribe to our feed using one of the below:

Podcast feed URL
Subscribe via iTunes - coming soon

HealthInvestor Asia twitter feed


Chinese biopharmaceutical company Innovent Biologics is looking to raise up to HK$3.3 billion (US$422 million) in its Hong Kong IPO. The company is selling 236 million shares, or 21% of the enlarged share capital, at an indicative range of HK$12.50-$14.00 per share. There has been strong support from institutional investors and cornerstones including Sequoia, Value Partners and Temasek. Joint sponsors are China Merchants Securities, Goldman Sachs, JP Morgan and Morgan Stanley. The deal is expected to price tomorrow.



The Future of Healthcare in Asia

Round table

Download the round table here

HealthInvestor UK